Skip to main content
Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
6.69
-0.06 (-0.89%)
At close: Apr 28, 2026, 4:00 PM EDT
6.70
+0.01 (0.15%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Profound Medical Revenue

In the year 2025, Profound Medical had annual revenue of $16.10M with 50.73% growth. Profound Medical had revenue of $5.98M in the quarter ending December 31, 2025, with 43.13% growth.

Revenue (ttm)
$16.10M
Revenue Growth
+50.73%
P/S Ratio
15.36
Revenue / Employee
$99,370
Employees
162
Market Cap
247.34M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202516.10M5.42M50.73%
Dec 31, 202410.68M3.48M48.35%
Dec 31, 20237.20M518.00K7.75%
Dec 31, 20226.68M-192.00K-2.79%
Dec 31, 20216.87M-431.00K-5.90%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inogen 348.67M
InfuSystem Holdings 143.44M
RxSight 134.48M
Sight Sciences 77.36M
Electromed 68.86M
CVRx, Inc. 56.65M
908 Devices 56.20M
TriSalus Life Sciences 45.15M
Revenue Rankings

PROF News

More News